I-Mab (NASDAQ:IMAB) said on Thursday that it has signed an agreement to acquire Bridge Health Biotech. As part of the deal, I-Mab will provide an initial payment of $1.8M to Bridge Health shareholders ...

Over 30 million people in Europe live with a rare disease. Most of them still lack access to accurate diagnosis or treatment ...

Johannes Fruehauf left Germany for the United States more than 20 years ago to propel his scientific career. But amid ...

In a nation with ambitions as bold as Qatar’s, healthcare is more than a service — it is a cornerstone of progress, ...

The new space is a free community service meant to help healthcare entrepreneurs connect with potential funders.

Brisbane-based biotech company Eclipse Ingredients has launched publicly with $7.2 million in funding after navigating a long ...

Oscar-winning actress Lupita Nyong’o is sharing about her experience of being diagnosed with uterine fibroids, using the ...

Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...

Prof. Ganesan Karthikeyan, Executive Director of THSTI, opened the event by emphasizing the urgent need for multidisciplinary ...

The Philadelphia gene therapy company said the cuts were "part of a broader effort to right size the organization." ...

The Health Ministry, Bandung Institute of Technology (ITB), and Del Technology Institute (IT Del) have inked a memorandum of understanding to bolster ...

Lumos Diagnostics signs exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of FebriDX in US.